Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board

Barcelona, Spain, January 7th, 2021 – Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics targeting the Myc oncoprotein for cancer treatment, announces today that has appointed veteran pharma and biotech executive Giacomo Di Nepi as Chairman of the Board.  Mr. Di Nepi has accumulated nearly 40 years of global … Continue reading Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board